2026 ICD-10-CM Diagnosis Code E83.111Hemochromatosis due to repeated red blood cell transfusions

ICD-10-CM CodesE00–E89E70-E88E83

ICD-10-CM E83.111
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

E83.111 is a billable ICD-10-CM diagnosis code for hemochromatosis due to repeated red blood cell transfusions. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as hemochromatosis following repeated red blood cell transfusion. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.

Code Identity

ICD-10-CM Code
E83.111
Billable Status
Yes — Valid for Submission
Code Describes
Hemochromatosis due to repeated red blood cell transfusions
Short Description
Hemochromatosis due to repeated red blood cell transfusions
Same as the full description in the CMS dataset.
Parent Code
Hemochromatosis

Code Classification

ChapterE00–E89Endocrine, nutritional and metabolic diseases
SectionE70-E88Metabolic disorders
CategoryE83Disorders of mineral metabolism
This CodeE83.111Hemochromatosis due to repeated red blood cell transfusions

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Hemochromatosis following repeated red blood cell transfusion
  • Secondary hemochromatosis

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Iron overload due to repeated red blood cell transfusions
  • Transfusion (red blood cell) associated hemochromatosis

Index to Diseases and InjuriesGuidance

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Complication(s) (from) (of)
      • transfusion (blood) (lymphocytes) (plasma)
        • hemochromatosis
    • Hemochromatosis
      • due to repeated red blood cell transfusion
    • Overload
      • iron, due to repeated red blood cell transfusions
    • Transfusion
      • associated (red blood cell) hemochromatosis

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR END016
Other specified and unspecified nutritional and metabolic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Secondary Hemochromatosis

    hemochromatosis that is not inherited and is caused by iron overload from excessive consumption, multiple transfusions, or disorders of erythropoiesis.

Patient EducationClinical

Hemochromatosis

Hemochromatosis is a disease in which too much iron builds up in your body. Your body needs iron but too much of it is toxic. If you have hemochromatosis, you absorb more iron than you need. Your body has no natural way to get rid of the extra iron. It stores it in body tissues, especially the liver, heart, and pancreas.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert E83.111 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
275.02 Hemochromatos-rbc trans
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About E83.111Overview

Is E83.111 (Hemochromatosis) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report hemochromatosis due to repeated red blood cell transfusions on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of E83.111?

Under the General Equivalence Mappings, hemochromatosis due to repeated red blood cell transfusions converts to ICD-9-CM 275.02 (hemochromatos-rbc trans). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.